SAGE THERAPEUTICS INC's ticker is and the CUSIP is 78667J958. A total of 3 filers reported holding SAGE THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $19 | +35.7% | 1,800 | +125.0% | 0.00% | – |
Q1 2024 | $14 | -95.1% | 800 | -93.9% | 0.00% | – |
Q4 2023 | $283 | -78.0% | 13,100 | -79.0% | 0.00% | -100.0% |
Q3 2023 | $1,286 | +349.7% | 62,500 | +924.6% | 0.00% | – |
Q2 2023 | $286 | +673.0% | 6,100 | +577.8% | 0.00% | – |
Q1 2023 | $37 | +68.2% | 900 | +50.0% | 0.00% | – |
Q4 2022 | $22 | -99.9% | 600 | -25.0% | 0.00% | – |
Q3 2022 | $31,000 | -98.7% | 800 | -98.9% | 0.00% | -100.0% |
Q2 2022 | $2,370,000 | -6.2% | 73,400 | -3.9% | 0.00% | +50.0% |
Q1 2022 | $2,528,000 | -19.4% | 76,400 | +3.7% | 0.00% | -33.3% |
Q4 2021 | $3,135,000 | -20.3% | 73,700 | +7.4% | 0.00% | -25.0% |
Q3 2021 | $3,935,000 | -1.2% | 68,600 | -2.1% | 0.00% | 0.0% |
Q2 2021 | $3,982,000 | -44.1% | 70,100 | +7271.2% | 0.00% | -69.2% |
Q1 2021 | $7,118,000 | +200.3% | 951 | +247.1% | 0.01% | +333.3% |
Q4 2020 | $2,370,000 | -58.3% | 274 | -70.6% | 0.00% | -62.5% |
Q3 2020 | $5,690,000 | +461.1% | 931 | +281.6% | 0.01% | +300.0% |
Q2 2020 | $1,014,000 | +45.9% | 244 | +0.8% | 0.00% | +100.0% |
Q1 2020 | $695,000 | -41.3% | 242 | +47.6% | 0.00% | -66.7% |
Q4 2019 | $1,183,000 | -55.1% | 164 | -12.8% | 0.00% | -62.5% |
Q3 2019 | $2,637,000 | -43.3% | 188 | -26.0% | 0.01% | -38.5% |
Q2 2019 | $4,650,000 | +509.4% | 254 | +429.2% | 0.01% | +550.0% |
Q1 2019 | $763,000 | -28.2% | 48 | -56.8% | 0.00% | -33.3% |
Q4 2018 | $1,063,000 | -29.0% | 111 | +4.7% | 0.00% | -40.0% |
Q3 2018 | $1,497,000 | -29.7% | 106 | -22.1% | 0.01% | -37.5% |
Q2 2018 | $2,128,000 | +3633.3% | 136 | +67.9% | 0.01% | +166.7% |
Q1 2018 | $57,000 | -19.7% | 81 | -87.4% | 0.00% | 0.0% |
Q4 2017 | $71,000 | -83.9% | 643 | +62.0% | 0.00% | -83.3% |
Q3 2017 | $440,000 | +714.8% | 397 | +41.3% | 0.02% | +800.0% |
Q2 2017 | $54,000 | -55.7% | 281 | -4.7% | 0.00% | -60.0% |
Q1 2017 | $122,000 | +258.8% | 295 | -33.0% | 0.01% | +150.0% |
Q4 2016 | $34,000 | -57.0% | 440 | -42.1% | 0.00% | -60.0% |
Q3 2016 | $79,000 | +113.5% | 760 | +1087.5% | 0.01% | +150.0% |
Q2 2016 | $37,000 | +3600.0% | 64 | +1500.0% | 0.00% | – |
Q1 2016 | $1,000 | -99.5% | 4 | -93.0% | 0.00% | -100.0% |
Q3 2015 | $184,000 | +607.7% | 57 | -20.8% | 0.01% | +550.0% |
Q2 2015 | $26,000 | – | 72 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 32,000 | $3,065,000 | 0.03% |
IMC-Chicago, LLC | 14,000 | $1,341,000 | 0.00% |
SIMPLEX TRADING, LLC | 111 | $1,063,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
JPMORGAN CHASE & CO | 1,100 | $105,000 | 0.00% |